← Back to Search

Men With Prostate Cancer Planned for Receiving ADT for Prostate Cancer

N/A

Recruiting

Led By Vivek Narayan, MD

Research Sponsored by Vivek Narayan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Men with prostate cancer over 18 years of age who are currently receiving or will be receiving treatment with at least 6 months of ADT

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 18 months

Awards & highlights

Study Summary

This trial aims to improve cardiovascular care for prostate cancer patients undergoing ADT by providing them with a web-based tool to educate them about their individual cardiovascular risks and how to manage them. The study will test

Who is the study for?

This trial is for men over 18 with prostate cancer who are currently on or will start androgen deprivation therapy (ADT) for at least six months. Participants need to be able to read and understand English.Check my eligibility

What is being tested?

The CARE-PC study is testing a web-based application designed to educate prostate cancer patients about their cardiovascular risks associated with ADT, provide personalized risk assessments, and offer guidelines for risk reduction.See study design

What are the potential side effects?

Since this trial involves the use of an educational web tool rather than a medical treatment, there are no direct side effects related to medication. However, participants may experience stress or anxiety from learning about their cardiovascular risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am a man over 18 with prostate cancer and will be on hormone therapy for at least 6 months.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 18 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~18 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CARE-PC Web-Based Application Completion Rate

Secondary outcome measures

Patient acceptance and perception of the web-based application

Percent accuracy of patient-derived CV- and prostate cancer-related data elements

Prevalence of CV risk factors/disease at the time of CARE-PC web-based application participation

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Men With Prostate Cancer Planned for Receiving ADTExperimental Treatment1 Intervention

Men with prostate cancer > 18 years of age who are currently receiving or will be receiving treatment with ≥ 6 months of systemic androgen deprivation therapy (ADT).

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Vivek NarayanLead Sponsor

National Comprehensive Cancer NetworkNETWORK

115 Previous Clinical Trials

7,535 Total Patients Enrolled

5 Trials studying Prostate Cancer

301 Patients Enrolled for Prostate Cancer

Vivek Narayan, MDPrincipal InvestigatorUniversity of Pennsylvania

4 Previous Clinical Trials

66 Total Patients Enrolled

1 Trials studying Prostate Cancer

18 Patients Enrolled for Prostate Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are individuals currently able to enroll in this ongoing medical study?

"Affirmative. Details on clinicaltrials.gov imply that this investigation is actively seeking suitable participants. The trial was initially published on November 14, 2023, and the latest revision occurred on February 26, 2024. This research endeavor aims to enlist a total of 100 individuals from one designated site."

Answered by AI

What is the total number of participants enrolled in this research investigation?

"Yes, information on clinicaltrials.gov indicates that this research is currently enrolling participants. This trial was first listed on November 14th, 2023 and last revised on February 26th, 2024. The aim is to recruit a total of 100 patients from one site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study

Vivek Narayan 2023. "The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06064149.